Takeda Pharmaceutical
281 hedge funds and large institutions have $799M invested in Takeda Pharmaceutical in 2022 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 88 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 88
2% less funds holding
Funds holding: 286 → 281 (-5)
Holders
281
Holding in Top 10
1
Calls
$39.1M
Puts
$4.76M
Top Buyers
| 1 | +$55M | |
| 2 | +$24.4M | |
| 3 | +$12.2M | |
| 4 |
VanEck Associates
New York
|
+$12.1M |
| 5 |
Renaissance Technologies
New York
|
+$11.7M |
Top Sellers
| 1 | -$35.7M | |
| 2 | -$11.8M | |
| 3 | -$8.54M | |
| 4 |
Goldman Sachs
New York
|
-$8.54M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.34M |